Lexaria Bioscience Corp.
LEXXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for LEXX. That does not mean none is planned.
Get an email about LEXX's next catalysts
Track Lexaria Bioscience (LEXX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
LEXX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.90 | FQ end Aug/2026 | Call: tbd
Market Overview
Stock performance and key metrics
No drugs found in this phase.
Frequently asked questions
When is Lexaria Bioscience Corp.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Lexaria Bioscience Corp. (LEXX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track LEXX biotech catalysts?→
Add LEXX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Lexaria Bioscience Corp.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.